Danaher Co. (NYSE:DHR) Position Raised by Parsons Capital Management Inc. RI

Parsons Capital Management Inc. RI increased its position in Danaher Co. (NYSE:DHR) by 38.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 62,807 shares of the conglomerate’s stock after acquiring an additional 17,409 shares during the period. Parsons Capital Management Inc. RI’s holdings in Danaher were worth $14,417,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Decker Retirement Planning Inc. acquired a new stake in Danaher in the fourth quarter worth about $31,000. Teachers Insurance & Annuity Association of America acquired a new position in shares of Danaher during the third quarter valued at approximately $39,000. MidAtlantic Capital Management Inc. acquired a new stake in Danaher in the third quarter worth approximately $40,000. FSA Wealth Management LLC bought a new position in Danaher during the 3rd quarter valued at $50,000. Finally, Darwin Wealth Management LLC acquired a new position in shares of Danaher during the 3rd quarter valued at $55,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Up 0.1 %

NYSE:DHR opened at $245.95 on Monday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company has a market capitalization of $177.65 billion, a P/E ratio of 46.94, a P/E/G ratio of 4.43 and a beta of 0.83. The stock’s 50 day moving average price is $235.33 and its 200 day moving average price is $253.62. Danaher Co. has a 52 week low of $225.42 and a 52 week high of $281.70.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date is Friday, December 27th. Danaher’s payout ratio is presently 20.61%.

Wall Street Analysts Forecast Growth

DHR has been the subject of several research reports. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research note on Friday, December 13th. Stephens reiterated an “overweight” rating and issued a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Royal Bank of Canada cut their price objective on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Finally, Scotiabank started coverage on shares of Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price for the company. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $285.55.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.